fashion -WSS

fashion

author：comprehensive 2025-09-05 13:33:10 - browse：2292

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Medicare has officially expanded its coverage policy for brain scans that detect a brain plaque associated with Alzheimer’s disease, the agency announced on Friday.

Amyloid PET scans are important tools to help determine whether patients with mild cognitive impairment are good candidates for new Alzheimer’s drugs, including Eisai and Biogen’s drug Leqembi, which means there will likely be an increase in demand for the scans as uptake increases.

Previously, Medicare limited coverage for the drug to patients enrolled in clinical studies, and only covered one scan in a patient’s lifetime. The new coverage policy removes those restrictions and delegates decisions about how many scans to cover to regional Medicare administrators.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Let's speed up science by embracing open access publishing

WSS

Departing Stanford president retracts two papers

As pharma fights Medicare drug negotiation, hospitals, docs silent

How to increase colonoscopy rates? Looks like an AI can help

At ASCO, AstraZeneca reports strong data for breast cancer drug

Cord blood banking comes at a high cost to babies

Drug firms test therapies to halt Alzheimer’s before symptoms arise

hotspot

fashion

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

Neuroscience startup Neumora files for IPO

Hollywood unions extend contract negotiations for actors

Departing Stanford president retracts two papers

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

ASCO: Palliative care found as helpful given virtually as in person

State Dept. review finds Biden bears some blame for Afghanistan failures

Apellis safety probe of eye disease drug centers on injection needle

Medical leaders decry Supreme Court decision on affirmative action

2024 GOP presidential candidates spar over abortion in debate

focus

Shifting the focus from loneliness to social health

Study finds new variant for Parkinson’s in African populations

Radiation, mainstay of cancer treatment, begins a fade

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Shifting the focus from loneliness to social health

What do new weight loss drugs mean for bariatric surgery?

hotspot

explore

Wikipedia

hotspot